Naphthalanotherapy Reduces Angiogenetic Factor in Psoriatic Lesion

Acta Dermatovenerologica Croatica

Volumn 12, Issue 1, 2004, Pages 7-11

  Vržogić, Pero ^a   Jakić Razumović, Jasminka ^b   Lipozenčić, Jasna ^b  

^a Naftalan Spec Hosp for Med Rehab   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

F VIII factor of angiogenesis; Immunohistochemistry; Naphthalan treatment; Psoriasis

Indexed keywords

ANGIOGENIC FACTOR; DECALIN; MONOCLONAL ANTIBODY;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; NEOVASCULARIZATION (PATHOLOGY); PSORIASIS; SKIN BIOPSY;

ADMINISTRATION, TOPICAL; ANGIOGENESIS INHIBITORS; BATHS; FEMALE; HUMANS; MALE; NAPHTHALENES; NEOVASCULARIZATION, PHYSIOLOGIC; PSORIASIS; SKIN;

EID: 1942488902     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Polo M. Il milione, 1298. In: Knust TA. Von Venedig nach China. Darmstadt: Wissenschaftliche Buchgesellschaft; 1996. p. 43.
2. Vržogić P, Jakić-Razumović J, Pašić A. Effect of nahthalan on epidermal proliferation activity and CD3, CD4, and CD8 lymphocyte count. Acta Dermatovenerol Croat 2003;11:65-9.
3. Barišić-Druško V, Paljan D, Kansky A, Vujasinović S. Prevalence of psoriasis in Croatia. Acta Dermvenereol (Stockh) 1989;146:178-9.
4. Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis 2002;5:231-6.
5. Krnjević-Pezić G, Vržogić P, Ostrogović Ž, Smeh-Skrbin A, Dobrić I. Some haemotological and biochemical parameters in psoriatic patients treated with naphthalan. Acta Dermatovenerol Croat 1997;5:49-53.
6. Barker JN. Pathophysiology of psoriasis. Lancet 1991; 338:227-30.
7. Creamer D, Allen M, Sousa A, Poston R, Barker J. Altered vascular endothelium integrin expression in psoriasis. Am J Pathol 1995;147:1661-7.
8. Nickoloff BJ. Characterization of lymphocyte-dependent angiogenesis using SCID mouse: human skin model of psoriasis. J Investig Dermatol Symp Proc 2000;5:67-73.
9. Creamer JD, Allen MH, Sousa A, Poston R, Barker JN. Localization of endothelial proliferation and microvascular expansion in active plaques psoriasis. Br J Dermatol 1997;136:859-65.
10. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, et al. Over expression of transforming growth factor - a in psoriatic epidermis. Science 1989; 243:811-4
11. Kuroda K, Sapadin A, Shoji T, Fleischmajer R, Lebwohl M. Altered expression of angiopoietins and Tie 2 endothelium receptor in psoriasis. J Invest Dermatol 2001; 116:713-20.
12. Real Life's Shark Cartilage Information Exchange Information. The National Psoriasis Foundation (USA) and the Canadian Psoriasis Foundation. Available from: www.relife.com/psoriasisfacts.html. Accessed: October 15, 2003.
13. Jeong GB. What is angiogenesis? Available from: http://chungbuk.ac.kr/∼gbjeong/research.htlm. Accessed: October 15, 2003.
14. Hernandez GL, Volpert OV, Iniguez MA, Lorenzo E, Martinez-Martinez S, Grau R, et al. Selective inhibition of vascular endothelial growth factor - mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T-cells and cyclooxygenase 2. J Exp Med 2001;193:607-20.
15. Weinstein GD, van Scott EJ. Autoradiographic analysis of turnover times of normal and psoriatic dermis. J Invest Dermatol 1965;45:257-62.
16. th Congress of the European Academy of Dermatology and Venerology. Amsterdam, Netherlands; September 29 - October 3, 1999. J Eur Acad Dermatol Venerol 1999;12 Suppl2:306.
17. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999;38:241-51.
18. Sweet WL, Smoller BR. Differential proliferation of endothelial cells and keratinocytes in psoriasis and spongiotic dermatitis. J Cutan Pathol 1997;24:356-63.
19. Creamer JD, Barker JN. Vascular proliferation and angiogenic factor in psoriasis. Clin Exp Dermatol 1995; 20:6-9.